284 related articles for article (PubMed ID: 31499192)
1. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.
Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z
Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5'-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway.
Sun X; Li S; Gan X; Qiu C; Chen K; Pei H; Wang Q; Li D; Li X; Yang D; Yang Y
J Hypertens; 2019 Nov; 37(11):2256-2268. PubMed ID: 31136458
[TBL] [Abstract][Full Text] [Related]
3. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
4. Plin5 inhibits proliferation and migration of vascular smooth muscle cell through interacting with PGC-1α following vascular injury.
Gan X; Zhao J; Chen Y; Li Y; Xuan B; Gu M; Feng F; Yang Y; Yang D; Sun X
Bioengineered; 2022 Apr; 13(4):10665-10678. PubMed ID: 35470759
[TBL] [Abstract][Full Text] [Related]
5. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.
Gu M; Wang Z; Feng F; Yang Y; Sun X; Yang D
J Cardiovasc Pharmacol; 2022 May; 79(5):739-748. PubMed ID: 35275098
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of VRK1 suppresses proliferation and migration of vascular smooth muscle cells and intima hyperplasia after injury via mTORC1/β-catenin axis.
Sun X; Zhao W; Wang Q; Zhao J; Yang D; Yang Y
BMB Rep; 2022 May; 55(5):244-249. PubMed ID: 35410639
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.
Hwang AR; Lee HJ; Kim S; Park SH; Woo CH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175802
[TBL] [Abstract][Full Text] [Related]
9. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
10. Galangin inhibits neointima formation induced by vascular injury
Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X
Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287
[No Abstract] [Full Text] [Related]
11. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells.
Sun X; Li S; Gan X; Chen K; Yang D; Yang Y
Aging (Albany NY); 2020 May; 12(10):9726-9744. PubMed ID: 32422606
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of polycomb repressor complex 2 ameliorates neointimal hyperplasia by suppressing trimethylation of H3K27 in vascular smooth muscle cells.
Liang J; Li Q; Cai W; Zhang X; Yang B; Li X; Jiang S; Tian S; Zhang K; Song H; Ai D; Zhang X; Wang C; Zhu Y
Br J Pharmacol; 2019 Sep; 176(17):3206-3219. PubMed ID: 31162630
[TBL] [Abstract][Full Text] [Related]
13. RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.
Sun J; Zhu Q; Yu X; Liang X; Guan H; Zhao H; Yao W
Atherosclerosis; 2023 Dec; 387():117391. PubMed ID: 38029612
[TBL] [Abstract][Full Text] [Related]
14. TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation.
Wu LP; Gong ZF; Wang H; Zhou ZS; Zhang MM; Liu C; Ren HM; Yang J; Han Y; Zeng CY
Acta Pharmacol Sin; 2020 Jan; 41(1):34-46. PubMed ID: 31515530
[TBL] [Abstract][Full Text] [Related]
15. Gastrodin inhibits cell proliferation in vascular smooth muscle cells and attenuates neointima formation in vivo.
Zhu L; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Int J Mol Med; 2012 Nov; 30(5):1034-40. PubMed ID: 22922870
[TBL] [Abstract][Full Text] [Related]
16. NCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.
Afzal TA; Luong LA; Chen D; Zhang C; Yang F; Chen Q; An W; Wilkes E; Yashiro K; Cutillas PR; Zhang L; Xiao Q
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27927633
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
19. OCT4 regulated neointimal formation in injured mouse arteries by matrix metalloproteinase 2-mediated smooth muscle cells proliferation and migration.
Ding X; Yan Y; Zhang C; Xu X; Yang F; Liu Y; Wang G; Qin Y
J Cell Physiol; 2021 Jul; 236(7):5421-5431. PubMed ID: 33372301
[TBL] [Abstract][Full Text] [Related]
20. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Liu Y; Ning WH; Shen XH; Guo DL; Guo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
